Articles

August 21, 2014 — Efforts over the past decade to improve the quality of care for cardiovascular disease patients and increase the use of evidence-based treatments have led to a significant drop...

In a community hospital and emergency medical services (EMS) system, the standard 12-lead electrocardiogram (ECG) is the primary and initial objective diagnostic tool used by emergency medical...

Robert Smith, a cardiologist at Saint Francis Hospital and Medical Center in Hartford, Conn., released the results of his retrospective study designed to compare single in-office automated blood...

In the current era of healthcare reform with the overarching goal of reducing healthcare costs, heart failure (HF) management has taken center stage. It is the leading cause of hospitalization for...

LipoScience Inc. announced the publication of the first large-scale real world study evidencing a link between low LDL-P and reduced cardiovascular disease (CVD) risk.

St. Jude Medical announced the completion of its acquisition of the privately held CardioMEMS Inc., developer of the CardioMEMS heart failure (HF) management system. The acquisition was...

CardioMEMS Heart Failure System FDA Approval

The U.S. Food and Drug Administration (FDA) granted market clearance to the CardioMEMS Heart Failure System, the first FDA-approved heart failure (HF) monitoring device shown in clinical trials to...

As a cardiovascular technology magazine editor, I keep tabs on what technology is in development and often have the opportunity to see the most cutting edge technology up close prior to U.S. Food...

genetic testing for coronary artery disease

Improved understanding of the molecular mechanism of atherogenesis will help identify disease-related pathways and biomarkers that may also help to predict the future risk in asymptomatic...

May 19, 2014 — A new study found that adding an electrocardiogram (ECG) to existing pre-participation screening of high school athletes increases the likelihood of identifying disorders associated...